Showing results (151-160 of 180) with videos related to
Sort By:
Pageof 18
Asian Pacific Journal of Cancer Prevention : APJCP|December 29, 2023
Cervical Cancer Screening Coverage at Tertiary Care Institutes Across IndiaRakhi Rai, Rohini Sehgal, Seema Singhal, et al.Diabetes Research and Clinical Practice|September 4, 2020
Glycemic profile of women with normoglycemia and gestational diabetes mellitus during early pregnancy using continuous glucose monitoring systemCharandeep Singh, Yashdeep Gupta, Alpesh Goyal, et al.Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.Transplantation|January 17, 2015
Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplantsJoseph R Leventhal, Mary J Elliott, Esma S Yolcu, et al.JAMA Oncology|March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical TrialLocke J Bryan, Carla Casulo, Pamela B Allen, et al.Cancer|October 6, 2005
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myelomaJames R Berenson, Sundar Jagannath, Bart Barlogie, et al.European Journal of Haematology|April 12, 2011
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patientsMaurizio Zangari, Monette Aujay, Fenghuang Zhan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomibPaul G Richardson, Hannah Briemberg, Sundar Jagannath, et al.The New England Journal of Medicine|June 27, 2003
A phase 2 study of bortezomib in relapsed, refractory myelomaPaul G Richardson, Bart Barlogie, James Berenson, et al.Pageof 18